ARTICLE | Company News
Arakis and Penwest to co-develop AD121
November 13, 2000 8:00 AM UTC
The companies will collaborate to develop a timed release formulation of AD121 to treat rheumatoid arthritis. Arakis ( Cambridge, U.K.) will contribute preclinical and clinical development expertise. ...